Successful treatment with eculizumab in refractory myasthenia gravis with both anti-AChR and anti-LRP4 antibodies: two case reports
{{output}}
Introduction: Generalized myasthenia gravis (gMG), an antibody-induced autoimmune disorder of the neuromuscular junction, is characterized by fluctuating skeletal muscle weakness and fatigability. Approximately 85% of patients wi... ...
